(Q90032067)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31505092%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

review article

2 references

25 June 2021

Management of portal hypertension and ascites in polycystic liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31505092%20AND%20SRC:MED&resulttype=core&format=json

gastrointestinal bleeding

10 April 2020

main subject

1 reference

25 June 2021

1 reference

25 June 2021

polycystic liver disease

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31505092%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

Joost P H Drenth

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31505092%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

author name string

Eric T T L Tjwa

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31505092%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

publication date

20 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31505092%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

1 November 2019

1 reference

25 June 2021

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31505092%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

25 June 2021

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31505092%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31505092%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

page(s)

2024-2033

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31505092%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

10 April 2020

copyright license

1 reference

25 June 2021

0 references

Clinical experience with adult polycystic liver disease

1 reference

12 December 2020

Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis.

1 reference

12 December 2020

Refractory ascites associated with polycystic liver disease. Treatment with peritoneovenous shunt

1 reference

12 December 2020

Esophageal Varices in Adult Patients with Polycystic Kidney and Liver Disease

1 reference

12 December 2020

The use of ultrasound in the diagnosis of cystic lesions of the liver and upper abdomen and in the detection of ascites

1 reference

12 December 2020

Bleeding oesophageal varices and hepatic dysfunction in adult polycystic kidney disease.

1 reference

12 December 2020

The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the National Digestive Diseases Advisory Board

1 reference

12 December 2020

The role of imaging in patients with ascites

1 reference

12 December 2020

Hepatic venous outflow obstruction in autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment

1 reference

12 December 2020

Budd-Chiari syndrome in autosomal dominant polycystic kidney disease: a complication of nephrectomy in patients with liver cysts

1 reference

12 December 2020

Case report: variceal haemorrhage due to polycystic liver treated by transhepatic intervention

1 reference

12 December 2020

Ascites in a polycystic patient

1 reference

12 December 2020

Budd-Chiari syndrome following pretransplant mononephrectomy in an autosomal dominant polycystic kidney disease patient with liver cysts

1 reference

12 December 2020

Laparoscopic fenestration in polycystic liver disease

1 reference

12 December 2020

Adult polycystic liver disease: is fenestration the most adequate operation for long-term management?

1 reference

12 December 2020

Successful transjugular intrahepatic portosystemic shunt creation in a patient with polycystic liver disease

1 reference

12 December 2020

Polycystic liver disease: an unusual cause of bleeding varices

1 reference

12 December 2020

Portal hypertension due to extensive hepatic cysts in autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Specific vascular complications of orthotopic liver transplantation with preservation of the retrohepatic vena cava: review of 1361 cases

1 reference

12 December 2020

Transjugular intrahepatic portosystemic shunt for the treatment of intractable ascites in a patient with polycystic liver disease

1 reference

12 December 2020

Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma.

1 reference

12 December 2020

The use and misuse of transjugular intrahepatic portasystemic shunts

1 reference

12 December 2020

A case of successful management of portosystemic shunt with autosomal dominant polycystic kidney disease by balloon-occluded retrograde transvenous obliteration and partial splenic embolization

1 reference

12 December 2020

Transjugular intrahepatic portosystemic shunt placement in the setting of polycystic liver disease: questioning the contraindication

1 reference

12 December 2020

Polycystic liver: an unusual cause of bleeding esophageal varices

1 reference

12 December 2020

Intravascular embolization therapy in a patient with an enlarged polycystic liver

1 reference

12 December 2020

Hepatic vein stenting for recurrent ascites in polycystic liver and kidney disease

1 reference

12 December 2020

Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome

1 reference

12 December 2020

Transjugular intrahepatic portosystemic shunt creation in a polycystic liver facilitated by hybrid cross-sectional/angiographic imaging

1 reference

12 December 2020

Model for end-stage liver disease (MELD) exception for polycystic liver disease

1 reference

12 December 2020

Inferior vena cava stenting: a safe and effective treatment for intractable ascites in patients with polycystic liver disease.

1 reference

12 December 2020

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

12 December 2020

Portal hypertension and its complications

1 reference

12 December 2020

Somatostatin analogues reduce liver volume in polycystic liver disease

1 reference

12 December 2020

Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease

1 reference

12 December 2020

Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation

1 reference

12 December 2020

Surgical management and longterm follow-up of non-parasitic hepatic cysts

1 reference

12 December 2020

Management of nonparasitic hepatic cysts

1 reference

12 December 2020

Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases.

1 reference

12 December 2020

Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension

1 reference

12 December 2020

Extended liver resection for polycystic liver disease can challenge liver transplantation.

1 reference

12 December 2020

Native nephrectomy for autosomal dominant polycystic kidney disease: before or after kidney transplantation?

1 reference

12 December 2020

Management of hepatorenal syndrome in patients with cirrhosis.

1 reference

12 December 2020

[Portosystemic shunt surgery between TIPS and liver transplantation]

1 reference

12 December 2020

Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study

1 reference

12 December 2020

Management of hepatic vascular diseases.

1 reference

12 December 2020

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

1 reference

12 December 2020

Complications arising in simple and polycystic liver cysts.

1 reference

12 December 2020

Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012

1 reference

12 December 2020

Symptomatic polycystic liver disease treated with transcatheter hepatic arterial embolization and inferior vena cava stenting: a case report.

1 reference

12 December 2020

Intravascular embolization therapy in patients with enlarged polycystic liver

1 reference

12 December 2020

Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

1 reference

12 December 2020

Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.

1 reference

12 December 2020

Bilateral Nephrectomy for Autosomal Dominant Polycystic Kidney Disease and Timing of Kidney Transplant: A Review of the Technical Advances in Surgical Management of Autosomal Dominant Polycystic Disease

1 reference

12 December 2020

Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease

1 reference

12 December 2020

1 reference

12 December 2020

Development and Validation of a Disease-Specific Questionnaire to Assess Patient-Reported Symptoms in Polycystic Liver Disease

1 reference

12 December 2020

Outcomes and Durability of Hepatic Reduction after Combined Partial Hepatectomy and Cyst Fenestration for Massive Polycystic Liver Disease

1 reference

12 December 2020

Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial

1 reference

12 December 2020

Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shunt

1 reference

12 December 2020

Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease

1 reference

12 December 2020

Center is an important indicator for choice of invasive therapy in polycystic liver disease

1 reference

12 December 2020

Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases

1 reference

12 December 2020

Efficacy and Safety of Aspiration Sclerotherapy of Simple Hepatic Cysts: A Systematic Review

1 reference

12 December 2020

Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes

1 reference

12 December 2020

Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy.

1 reference

12 December 2020

Functional Budd-Chiari Syndrome Associated With Severe Polycystic Liver Disease.

1 reference

12 December 2020

Diagnosis and Management of Hepatobiliary Complications in Autosomal Recessive Polycystic Kidney Disease

1 reference

12 December 2020

Polycystic liver disease: Hepatic venous outflow obstruction lesions of the non-cystic parenchyma have major consequences.

1 reference

12 December 2020

Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease.

1 reference

12 December 2020

Clinical management of polycystic liver disease.

1 reference

12 December 2020

Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study

1 reference

12 December 2020

Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo-controlled phase 2 trial.

1 reference

12 December 2020

Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations.

1 reference

12 December 2020

Impact of liver volume on polycystic liver disease-related symptoms and quality of life.

1 reference

12 December 2020

Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic Ascites.

1 reference

12 December 2020

Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?

1 reference

12 December 2020

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

1 reference

12 December 2020

Isolated Polycystic Liver Disease: An Unusual Cause of Recurrent Variceal Bleed.

1 reference

12 December 2020

Management of refractory cirrhotic ascites: challenges and solutions

1 reference

12 December 2020

Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts

1 reference

12 December 2020

Intravascular US Guidance for Direct Intrahepatic Portosystemic Shunt Creation in the Setting of Polycystic Liver Disease

1 reference

12 December 2020

Con: Tolvaptan for autosomal dominant polycystic kidney disease-do we know all the answers?

1 reference

12 December 2020

Clinical response after laparoscopic fenestration of symptomatic hepatic cysts: a systematic review and meta-analysis

1 reference

12 December 2020

Effect of tolvaptan on the prognosis of patients with hepatic ascites

1 reference

12 December 2020

Venous Stent Placement for Refractory Ascites due to Hepatic Venous Outflow Obstruction in Polycystic Liver Disease

1 reference

12 December 2020

The management of polycystic liver disease by tolvaptan

1 reference

12 December 2020

Identifiers

DOI

10.1111/LIV.14245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31505092%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31505092%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

1 reference